Ved å oppgi dette kan du få bedre tilpasset innhold om du har formell helsefaglig kompetanse.
Våre nettsider benytter cookies. Dersom cookien ikke er nødvendig for at nettsiden vår skal fungere,
vil den ikke lagres på din enhet med mindre du samtykker til dette.
Les mer om cookies her.
Ikke satt ennå.
Velkommen til symposium arrangert av UCB Pharma 21. oktober 2021, klokken 17:00-19:40.
Møtet arrangeres på konferansesenteret på Grand Hotel, Oslo.
Frist for påmelding er 12.oktober, det er begrenset plass for fysisk oppmøte, men det er også mulig å delta digitalt.
Main session: Therapeutic equivalence
17:00 – 17:30 | Keynote lecture: Are TNF-inhibitors therapeutically equivalent – and when is switching indicated?Josef Smolen (Vienna)
17:30 – 18:00 | Round table discussion: Implications for patient management in Norway. Participants:Josef Smolen (Vienna)Till Uhlig (Oslo)Marianne Wallenius(Trondheim)Bjørg Tilde Fevang (Bergen)
18:00 – 18:10 | Short break
Second session: Therapeutic Drug Monitoring (TDM)
18:10 – 18:30 | The role of TDM in rheumatology and beyondGuro Løvik Goll (Oslo)
18:30 – 18:40 | Q&A
19:00 Post-symposium dinner
Moderators: Tore K Kvien and Espen A Haavardsholm
Previous professor of Rheumatology at the University of Oslo from 1997 to the end of 2019 and was head of the Department of Rheumatology at Diakonhjemmet Hospital, Oslo, Norway, from 1994 to 2019. He is now professor emeritus and part time senior research advisor at Diakonhjemmet Hospital.
Professor in Rheumatology (University of Oslo, Institute of Clinical Medicine) and Head of Research and Innovation & Consultant Rheumatologist (Diakonhjemmet Hospital, Division of Rheumatology and Research)
Fotograf Nicolas Tourrenc, Diakonhjemmet sykehus
Josef Smolen is Emeritus Professor of Medicine at the Medical University of Vienna, Austria. He received his MD degree from the University of Vienna, trained there in Immunology, Medicine and Rheumatology and was research fellow at the Arthritis Institute at the National Institutes of Health, Bethesda, MD, USA. 1989-2017 he was Chairman of 2nd Department of Medicine at Hietzing Hospital and 1995-2018 Professor of Medicine and Chairman of the Division of Rheumatology at Medical University of Vienna, where he also acted as Chairman of the Department of Medicine 3 2007-2018.
Specialist in rheumatology and senior physician at the Division of Rheumatology and Research, Diakonhjemmet Hospital in Oslo.
She has a long-standing interest in immunology, biologic medicines and immunogenicity. She was clinical coordinator for rheumatology in the NOR-SWITCH and NOR-DRUM studies, and currently leads the Nor-vaC study.
Senior consultant at Dept of Rheumatology, St Olavs Hospital and professor at Institute of Neuromedicine and Movement Science (INB), NTNU (Norwegian University of Science and Technology), and with a special interest in pregnancy and rheumatic diseases.
Professor in Rheumatology at University of Oslo, Norway and Consultant rheumatologist at Diakonhjemmet Hospital
Consultant doctor of rheumatology og professor at the Department of clinical medicine, University of Bergen(MD, PhD).
Kjersti Bøe-WescheHCP Partner iPVU Norway Solution Lead Immunology Northern Europe kjersti.Boe-Wesche@ucb.comPhone+47 90631659
Hilde Pettersen Immunology Northern Europehilde.firstname.lastname@example.orgPhone:+47 90416241